DIN 02355655 — RESTASIS 0.05 %
RESTASIS is a emulsion of Cyclosporine (Ophthalmic) marketed by ABBVIE CORPORATION. The full Cyclosporine (Ophthalmic) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02355655
- Brand name
- RESTASIS
- Active ingredient
- Cyclosporine (Ophthalmic)
- Strength
- 0.05 %
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Ophthalmic calcineurin-inhibitor immunomodulator (topical anti-inflammatory eye drop)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cyclosporine (Ophthalmic) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02512629 | CEQUA | 0.09 % | SOLUTION | SUN PHARMACEUTICAL INDUSTRIES LIMITED | MARKETED |
| 02476835 | RESTASIS MULTIDOSE | 0.05 % | EMULSION | ABBVIE CORPORATION | MARKETED |
| 02462486 | TEVA-CYCLOSPORINE | 0.05 % | EMULSION | TEVA CANADA LIMITED | MARKETED |
| 02484137 | VERKAZIA | 0.1 % | EMULSION | APOTEX INC | MARKETED |